Impact of Moderate to Severe Chronic Kidney Disease for Long Term Survival of Implantable Cardioverter Defibrillator Patients in Taiwan

Meguid El Nahas, 2005, Chronic kidney disease: the global challenge, Lancet, 365, 331, 10.1016/S0140-6736(05)17789-7 Levey, 2007, Chronic kidney disease as a global public health problem: approaches and initiatives – a position statement from kidney disease improving global outcomes, Kidney Int, 72, 247, 10.1038/sj.ki.5002343 Hwang, 2010, Epidemiology, impact and preventive care of chronic kidney disease in Taiwan, Nephrol (Carlton), 15, S3, 10.1111/j.1440-1797.2010.01304.x Levey, 2009, Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the centers for disease control and prevention, Am J Kidney Dis, 53, 522, 10.1053/j.ajkd.2008.11.019 The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators, 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 Connolly, 2000, Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297 Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 Chao, 2014, Long-term prognosis in recipients of implantable cardioverter-defibrillators for secondary preventions in Taiwan – a multicenter registry study, Acta Cardiol Sin, 30, 22 Levey, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1 Manjunath, 2001, Prediction equations to estimate glomerular filtration rate: an update, Curr Opin Nephrol Hypertens, 10, 785, 10.1097/00041552-200111000-00009 Thompson, 1999, Explaining heterogeneity in meta-analysis: a comparison of methods, Stat Med, 18, 2693, 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V Turakhia, 2007, Impact of renal function on survival in patients with implantable cardioverter-defibrillators, Pacing Clin Electrophysiol, 30, 377, 10.1111/j.1540-8159.2007.00678.x Kramer, 2012, Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators, Heart Rhythm, 9, 42, 10.1016/j.hrthm.2011.08.031 Patton, 2014, Defibrillator therapy in chronic kidney disease: is it worth it?, Circ Arrhythm Electrophysiol, 7, 774, 10.1161/CIRCEP.114.002109 Pun, 2014, Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials, Am J Kidney Dis, 64, 32, 10.1053/j.ajkd.2013.12.009 Chen, 2014, A meta-analysis of mortality in end-stage renal disease patients receiving implantable cardioverter defibrillators (ICDs), PLoS One, 9 Makki, 2014, Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies, Europace, 16, 55, 10.1093/europace/eut277 Hage, 2013, Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: primary versus secondary prevention, Int J Cardiol, 165, 113, 10.1016/j.ijcard.2011.07.087 Tsai, 2003, Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study, Pacing Clin Electrophysiol, 26, 2083, 10.1046/j.1460-9592.2003.00324.x Chen, 2008, Implantable cardioverter defibrillator therapy: ten years experience in a medical center, Chang Gung Med J, 31, 81